The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.18 billion
P/E Ratio 29.55
Dividend Yield 0.00%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share N/A
Year To Date Return 29.81%
Earnings Yield 3.38%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    stock market gaining
    Share Gainers

    Why a2 Milk, AVZ, BHP, & GWA shares are charging higher

    These ASX shares have started the week strongly...

    Read more »

    man thinking about whether to invest in bitcoin
    Share Market News

    ASX 200 midday update: A2 Milk jumps on takeover speculation, Carsales rises

    The ASX 200 is in the red on Monday...

    Read more »

    green arrow representing a rise in the share price
    Consumer Staples & Discretionary Shares

    A2 Milk (ASX:A2M) share price up 11% amid fresh takeover talks

    A2 Milk shares are rising in response to a potential takeover effort.

    Read more »

    Share Market News

    These are the 10 most shorted ASX shares

    Short sellers are targeting these ASX shares...

    Read more »

    Share Market News

    How do you value the a2 Milk (ASX:A2M) share price?

    Down 50% in 2021. Is the a2 milk share price good value?

    Read more »

    Trees and a road shapes a dollar sign of green, indicating the share price movement of ASX eco companies
    Motley Fool Take Stock

    Is your portfolio ready for climate change?

    The IPCC report is stark reading

    Read more »

    falling milk asx share price represented by frowning woman tasting sour milk
    Record Lows

    When was the worst ever day for the A2 Milk (ASX:A2M) share price?

    A2 Milk has had a number of double-digit down days. But which one was the worst?

    Read more »

    happy investor, share price rise, increase, up
    Broker Notes

    a2 Milk (ASX:A2M) share price rises on bullish broker note

    This beaten down ASX share could be going higher...

    Read more »

    Little boy crying with his hand over his eyes.
    Share Fallers

    Here's why the A2 Milk (ASX:A2M) share price is down 18% in a month

    Why the Kiwi dairy share is under pressure right now.

    Read more »

    most shorted shares webjet
    Share Market News

    These are the 10 most shorted ASX shares

    Short sellers are targeting these ASX shares...

    Read more »

    Scared, wide-eyed man in pink t-shirt with hands covering mouth
    Broker Notes

    Top brokers name 3 ASX shares to sell next week

    Brokers aren't feeling overly positive on these shares...

    Read more »

    Child drinking milk out of glass
    Broker Notes

    Is it a good time to buy A2 Milk (ASX:A2M) shares in August 2021?

    Should you give the beaten up infant formula business a second chance

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    31 Oct 2024 $5.77 $0.02 0.35% 1,983,122 $5.73 $5.84 $5.68
    30 Oct 2024 $5.75 $-0.08 -1.37% 1,646,474 $5.90 $5.91 $5.75
    29 Oct 2024 $5.83 $0.10 1.75% 5,071,981 $5.79 $5.98 $5.78
    28 Oct 2024 $5.73 $-0.01 -0.17% 1,772,557 $5.74 $5.78 $5.70
    25 Oct 2024 $5.74 $-0.07 -1.20% 2,052,391 $5.81 $5.83 $5.73
    24 Oct 2024 $5.81 $-0.12 -2.02% 1,320,827 $5.91 $5.92 $5.81
    23 Oct 2024 $5.93 $0.04 0.68% 3,776,607 $5.89 $5.97 $5.88
    22 Oct 2024 $5.89 $-0.02 -0.34% 2,269,247 $5.91 $5.95 $5.78
    21 Oct 2024 $5.91 $0.01 0.17% 1,965,189 $6.03 $6.07 $5.90
    18 Oct 2024 $5.90 $-0.09 -1.50% 3,213,583 $5.96 $5.97 $5.86
    17 Oct 2024 $5.99 $-0.15 -2.44% 2,146,714 $6.18 $6.21 $5.98
    16 Oct 2024 $6.14 $-0.22 -3.46% 2,449,936 $6.30 $6.33 $6.12
    15 Oct 2024 $6.36 $-0.06 -0.93% 2,167,316 $6.33 $6.40 $6.28
    14 Oct 2024 $6.42 $-0.03 -0.47% 777,670 $6.50 $6.52 $6.41
    11 Oct 2024 $6.45 $-0.01 -0.15% 1,494,677 $6.46 $6.49 $6.42
    10 Oct 2024 $6.46 $0.11 1.73% 1,926,671 $6.37 $6.57 $6.33
    09 Oct 2024 $6.35 $0.00 0.00% 1,335,940 $6.30 $6.40 $6.27
    08 Oct 2024 $6.35 $-0.02 -0.31% 3,200,078 $6.33 $6.52 $6.19
    07 Oct 2024 $6.37 $0.14 2.25% 979,318 $6.24 $6.40 $6.23
    04 Oct 2024 $6.23 $-0.09 -1.42% 1,089,762 $6.30 $6.31 $6.17
    03 Oct 2024 $6.32 $-0.09 -1.40% 2,219,963 $6.33 $6.38 $6.24
    02 Oct 2024 $6.41 $0.18 2.89% 3,376,613 $6.20 $6.49 $6.19

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Warwick Lynton Every-Burns Non-Executive Director Aug 2016
    Mr Every-Burns has been a career Consumer Packaged Goods (CPG) executive of global scale. His executive roles have included a career with The Clorox Company of the USA as Senior Vice President, International, based in the USA and prior to that as VP Asia Pacific. His earlier roles included Managing Director of NationalPak Limited (the Glad Products Company ultimately acquired by Clorox) and a long career with Unilever plc where he was based in Australia. He is also Chair of the People and Remuneration Committee.
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note